Wealthcare Advisory Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,815
| Closed | -$208K | – | 612 |
|
|
2022
Q2 | $208K | Buy |
3,815
+21
| +0.6% | +$1.15K | 0.01% | 522 |
|
|
2022
Q1 | $207K | Sell |
3,794
-222
| -6% | -$12.1K | 0.01% | 511 |
|
|
2021
Q4 | $221K | Buy |
+4,016
| New | +$221K | 0.01% | 521 |
|
|
2021
Q2 | – | Sell |
-3,820
| Closed | -$170K | – | 1081 |
|
|
2021
Q1 | $170K | Buy |
+3,820
| New | +$170K | 0.01% | 519 |
|
|
2020
Q2 | – | Sell |
-1,542
| Closed | -$73K | – | 757 |
|
|
2020
Q1 | $73K | Sell |
1,542
-1,991
| -56% | -$94.3K | 0.01% | 432 |
|
|
2019
Q4 | $207K | Buy |
3,533
+254
| +8% | +$14.9K | 0.03% | 294 |
|
|
2019
Q3 | $175K | Sell |
3,279
-350
| -10% | -$18.7K | 0.03% | 294 |
|
|
2019
Q2 | $182K | Buy |
3,629
+448
| +14% | +$22.5K | 0.03% | 283 |
|
|
2019
Q1 | $166K | Sell |
3,181
-35
| -1% | -$1.83K | 0.03% | 265 |
|
|
2018
Q4 | $154K | Buy |
3,216
+199
| +7% | +$9.53K | 0.03% | 249 |
|
|
2018
Q3 | $151K | Sell |
3,017
-168
| -5% | -$8.41K | 0.03% | 262 |
|
|
2018
Q2 | $160K | Buy |
3,185
+329
| +12% | +$16.5K | 0.03% | 250 |
|
|
2018
Q1 | $139K | Buy |
2,856
+1,276
| +81% | +$62.1K | 0.03% | 234 |
|
|
2017
Q4 | $70K | Sell |
1,580
-1,236
| -44% | -$54.8K | 0.02% | 321 |
|
|
2017
Q3 | $143K | Buy |
2,816
+2,681
| +1,986% | +$136K | 0.04% | 174 |
|
|
2017
Q2 | $7K | Buy |
+135
| New | +$7K | ﹤0.01% | 84 |
|